Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous Leukemia

1995853 citationsJournal Articlebronze Open Access

Authors

R Zittoun · Hôtel-Dieu de Paris

Franco Mandelli · Sapienza University of Rome

Roel Willemze · Leiden University

Théo de Witte · Radboud University Nijmegen

Boris Labar · University Hospital Centre Zagreb

L Resegotti · Ospedale Maggiore

Franco Leoni ·

Abstract

Autologous as well as allogeneic bone marrow transplantation results in better disease-free survival than intensive consolidation chemotherapy with high-dose cytarabine and daunorubicin. Transplantation soon after a relapse or during a second complete remission might also be appropriate.

Topics & Keywords

Acute Myeloid Leukemia Research Hematopoietic Stem Cell Transplantation Retinoids in leukemia and cellular processes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 332, Issue 4, pp. 217-223

DOI: 10.1056/nejm199501263320403

Field-Weighted Citation Impact: 24.40